Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION (OTHER 210658) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 26, 2026 , from http://ppman.hank.ai/transparency/procedure/210658/by-state?code_type=OTHER
“INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION (OTHER 210658) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/210658/by-state?code_type=OTHER. Accessed
June 26, 2026 .
“INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION (OTHER 210658) by State,” HANK Price Transparency ,
accessed June 26, 2026 ,
http://ppman.hank.ai/transparency/procedure/210658/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
210658 — Inebilizumab-cdon 10 Mg/ml Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$198,864
National median
$146,649 – $213,175
IQR (p25 – p75)
5
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 210658 (OTHER), with interquartile range
State Median p25 p75
MT $201,210 $189,926 $212,270
CO $161,550 $143,084 $223,093